BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19643138)

  • 1. Over-expression of integrin beta3 can partially overcome the defect of integrin beta3 signaling in transglutaminase 2 null macrophages.
    Tóth B; Sarang Z; Vereb G; Zhang A; Tanaka S; Melino G; Fésüs L; Szondy Z
    Immunol Lett; 2009 Sep; 126(1-2):22-8. PubMed ID: 19643138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells.
    Tóth B; Garabuczi E; Sarang Z; Vereb G; Vámosi G; Aeschlimann D; Blaskó B; Bécsi B; Erdõdi F; Lacy-Hulbert A; Zhang A; Falasca L; Birge RB; Balajthy Z; Melino G; Fésüs L; Szondy Z
    J Immunol; 2009 Feb; 182(4):2084-92. PubMed ID: 19201861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils.
    Rose DM; Sydlaske AD; Agha-Babakhani A; Johnson K; Terkeltaub R
    Arthritis Rheum; 2006 Oct; 54(10):3363-71. PubMed ID: 17009310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transglutaminase 2 null macrophages respond to lipopolysaccharide stimulation by elevated proinflammatory cytokine production due to an enhanced αvβ3 integrin-induced Src tyrosine kinase signaling.
    Sarang Z; Köröskényi K; Pallai A; Duró E; Melino G; Griffin M; Fésüs L; Szondy Z
    Immunol Lett; 2011 Jul; 138(1):71-8. PubMed ID: 21420434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages engulfing apoptotic cells produce nonclassical retinoids to enhance their phagocytic capacity.
    Sarang Z; Joós G; Garabuczi É; Rühl R; Gregory CD; Szondy Z
    J Immunol; 2014 Jun; 192(12):5730-8. PubMed ID: 24850721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment.
    Falasca L; Iadevaia V; Ciccosanti F; Melino G; Serafino A; Piacentini M
    J Immunol; 2005 Jun; 174(11):7330-40. PubMed ID: 15905580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine produced from adenine nucleotides through an interaction between apoptotic cells and engulfing macrophages contributes to the appearance of transglutaminase 2 in dying thymocytes.
    Sándor K; Pallai A; Duró E; Legendre P; Couillin I; Sághy T; Szondy Z
    Amino Acids; 2017 Mar; 49(3):671-681. PubMed ID: 27236567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size.
    Boisvert WA; Rose DM; Boullier A; Quehenberger O; Sydlaske A; Johnson KA; Curtiss LK; Terkeltaub R
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):563-9. PubMed ID: 16410462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of transglutaminase 2 sensitizes for diet-induced obesity-related inflammation and insulin resistance due to enhanced macrophage c-Src signaling.
    Sághy T; Köröskényi K; Hegedűs K; Antal M; Bankó C; Bacsó Z; Papp A; Stienstra R; Szondy Z
    Cell Death Dis; 2019 Jun; 10(6):439. PubMed ID: 31165747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response.
    Ghanta KS; Pakala SB; Reddy SD; Li DQ; Nair SS; Kumar R
    J Biol Chem; 2011 Mar; 286(9):7132-8. PubMed ID: 21156794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
    Kotsakis P; Wang Z; Collighan RJ; Griffin M
    Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2 in the balance of cell death and survival.
    Fésüs L; Szondy Z
    FEBS Lett; 2005 Jun; 579(15):3297-302. PubMed ID: 15943974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-binding cassette transporter 1 and transglutaminase 2 act on the same genetic pathway in the apoptotic cell clearance.
    Iadevaia V; Rinaldi A; Falasca L; Pucillo LP; Alonzi T; Chimini G; Piacentini M
    Cell Death Differ; 2006 Nov; 13(11):1998-2001. PubMed ID: 16691213
    [No Abstract]   [Full Text] [Related]  

  • 14. The opsonin MFG-E8 is a ligand for the alphavbeta5 integrin and triggers DOCK180-dependent Rac1 activation for the phagocytosis of apoptotic cells.
    Akakura S; Singh S; Spataro M; Akakura R; Kim JI; Albert ML; Birge RB
    Exp Cell Res; 2004 Jan; 292(2):403-16. PubMed ID: 14697347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
    Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
    J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The integrin alpha5beta1 regulates chondrocyte hypertrophic differentiation induced by GTP-bound transglutaminase 2.
    Tanaka K; Yokosaki Y; Higashikawa F; Saito Y; Eboshida A; Ochi M
    Matrix Biol; 2007 Jul; 26(6):409-18. PubMed ID: 17490870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin beta 1 regulates phagosome maturation in macrophages through Rac expression.
    Wang QQ; Li H; Oliver T; Glogauer M; Guo J; He YW
    J Immunol; 2008 Feb; 180(4):2419-28. PubMed ID: 18250451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.
    Condello S; Cao L; Matei D
    FASEB J; 2013 Aug; 27(8):3100-12. PubMed ID: 23640056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration.
    Shweke N; Boulos N; Jouanneau C; Vandermeersch S; Melino G; Dussaule JC; Chatziantoniou C; Ronco P; Boffa JJ
    Am J Pathol; 2008 Sep; 173(3):631-42. PubMed ID: 18688035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
    Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
    Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.